MS Therapy Centre

Information About our News Feeds

The News Feeds displayed on this page are collected and updated from reputable 3rd Party Resources and Publications both National and International. The Wolverhampton MS Therapy Centre takes care in only including those resources it feels may benefit its Clients and Carers.

Occasionally some News Feeds are not made available for us to display and an error message may appear above, this simply means that a particular news article about MS is not available and does not affect the integrity of this site.

The Wolverhampton MS Therapy Centre cannot accept any legal responsibility for the accuracy or relevance of any information or any consequences that may arise from any actions taken from any information made available from the supplied News Feeds.

All information that is collected and displayed is offered in good faith.

Latest Multiple Sclerosis News

Disability Builds in Relapsing MS in Ways Not Tied to Relapses, Analysis Finds
Multiple Sclerosis News Today Jul 9, 2020 | 07:00 am
Disability appears to mostly accumulate in people with relapsing forms of multiple sclerosis (MS) in a progressive manner — rather than being due to relapses, a pooled analysis of patients in two Ocrevus (ocrelizumab) clinical trials shows. These findings, indicating[…]
Read more...
B-Cells Infected by Epstein-Barr Virus Linked to MS Relapse Risk in Study
Multiple Sclerosis News Today Jul 9, 2020 | 07:00 am
Immune B-cells that proliferate unchecked when infected by the Epstein-Barr virus (EBV) appear to increase the risk of relapses in patients with multiple sclerosis (MS), a mouse study suggests. The study, “Epstein Barr virus‐immortalized B lymphocytes exacerbate experimental autoimmune encephalomyelitis in[…]
Read more...
Siponimod Reduces Risk of Disability Progression Regardless of Prior Relapses in MS
Multiple sclerosis on Neurology Times Jun 4, 2020 | 03:21 am
The Novartis agent showed benefit in patients who had multiple sclerosis both with and without relapses.
Read more...
Ofatumumab Increases NEDA-3 Likelihood in MS Compared With Teriflunomide
Multiple sclerosis on Neurology Times Jun 4, 2020 | 03:11 am
Novartis’s anti-CD20 monoclonal antibody has been shown to increase the odds of patients with multiple sclerosis achieving no evidence of disease activity status by more than 3-fold in the first year and more than 8-fold in the second year.
Read more...
MS Disease Management & Prevention
Society for Multiple Sclerosis Patients in Pakistan Apr 25, 2019 | 04:52 am
Living with MS is not easy. Every day brings new challenges and struggles. Mild exacerbations in MS symptoms fade away on their own and therefore are not worrisome. However, the patient needs treatment for severe relapses or’ flare-ups’ as they[…]
Read more...
MS Patient Meetup April 2019
Society for Multiple Sclerosis Patients in Pakistan Apr 22, 2019 | 06:19 am
After the successful video and radio campaign for multiple sclerosis awareness, the Society for Multiple Sclerosis Patients in Pakistan (SMSPP) is delighted to announce a Pre-Ramzan MS Patient Meetup to be held in Lahore at Hotel Sunfort, Liberty Market. The[…]
Read more...